OLUMIANT (baricitinib) tablets. FDA Approved
OLUMIANT (baricitinib) tablets
INDICATIONS AND USAGE
OLUMIANT® is a Janus kinase (JAK) inhibitor indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more TNF antagonist therapies. Limitation of Use: Use of OLUMIANT in combination with other JAK inhibitors, biologic DMARDs, or with potent immunosuppressants such as azathioprine and cyclosporine is not recommended.
DOSAGE FORMS & STRENGTHS: Tablets (not scored): 2 mg
Manufactured By: Eli Lilly and Company
Prescribing Information URL: Click Here
HOW TO MAKE AN ENQUIRY FOR OLUMIANT (baricitinib) tablets?
FDA approved Anti-Cancer medicine OLUMIANT (baricitinib) tablets is available upon request. To get best retail price of OLUMIANT (baricitinib) tablets India, For emergency product orders call 8750295029 (Mr. Neeraj Nagpal) or For enquires email firstname.lastname@example.org For advanced treatments in India, Medvitaz Pharma Solution can even help patient to discuss with rheumatologist.